Lidocaine/Lincomycin

利多卡因/林可霉素

Report date: 2026/02/13 10:40:18

Base Information

Drug NameLidocaine/Lincomycin
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators50S ribosomal subunit inhibitors
TargetsSodium channel alpha subunit50S ribosomal subunit
Therapy Area/IndicationsBurns
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes LidocaineLincomycin Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBurns
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A